iRhythm Technologies Inc Stock News

Element Science, an innovative health technology company pioneering a next-generation digital wearable platform focused on high-risk cardiovascular patients transitioning from the hospital-to-home, an

Equities analysts predict that Irhythm Technologies Inc (NASDAQ:IRTC) will announce $63.84 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have provided

Aviva PLC bought a new stake in Irhythm Technologies Inc (NASDAQ:IRTC) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 26

iRhythm Technologies, Inc. (NASDAQ:IRTC) came out with its annual results last week, and we wanted to see how the...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Irhythm Technologies (NASDAQ:IRTC) had its price target raised by equities research analysts at Canaccord Genuity from $107.00 to $112.00 in a research note issued on Friday, BenzingaRatingsTable repo

Irhythm Technologies Inc (NASDAQ:IRTC) was up 8.2% on Friday after Canaccord Genuity raised their price target on the stock from $107.00 to $112.00. Canaccord Genuity currently has a buy rating on the

IRTC earnings call for the period ending December 31, 2019.

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Irhythm Technologies (IRTC), Madrigal Pharmaceuticals

Analysts fell to the sidelines weighing in on Irhythm Technologies (IRTC) and Nektar Therapeutics (NKTR) with neutral ratings, indicating that the experts

iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2019 Earnings Conference Call February 27, 2020, 04:30 PM ET Company Participants Leigh Salvo - IR Kevin King - Pres

IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -25.00% and 0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -25.00% and 0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

SAN FRANCISCO, Feb. 27, 2020 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.

ETRADE Capital Management LLC lessened its holdings in shares of Irhythm Technologies Inc (NASDAQ:IRTC) by 14.0% during the 4th quarter, according to its most recent disclosure with the SEC. The insti